Marksans Pharma consolidated net profit rises 43.83% in the September 2026 quarter

Sales rise 30.50% to Rs 940.17 crore

Net profit of Marksans Pharma rose 43.83% to Rs 141.31 crore in the quarter ended September 2026 as against Rs 98.25 crore during the previous quarter ended September 2025. Sales rose 30.50% to Rs 940.17 crore in the quarter ended September 2026 as against Rs 720.41 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	940.17	720.41	31
OPM %	22.79	20.06	-
PBDT	225.61	160.25	41
PBT	193.50	133.33	45
NP	141.31	98.25	44

Powered by Capital Market - Live News